Production, Purification, & Characterization of Oncolytic Herpes Simplex Virus for Viro-Oncotherapies

Time: 3:00 pm
day: Day Two


  • Oncolytic herpes simplex virus (HSV) can be modified to target cancer cells and directly kill them as well as to activate the immune system to recognize and attack the tumor
  • Optimized approach for the production and purification of HSV and readiness for scale up manufacturing.
  • Multilevel characterization of process and product supporting manufacturing